February 1, 2012
By:Simon Chalk
Introducing a new way to think about sharing information in a patent-driven industry.
 |
February 1, 2012
By:Angie Drakulich
Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference.
|
January 1, 2012
By:G. Steven Burrill
Greater emphasis on focus and efficiency for companies as market demands value in 2012.
|
January 1, 2012
By:Angie Drakulich
The benefits of harmonization may be on industry's wish list, but buying into change is another story.
|
December 1, 2011
By:John Castellani
Political leaders need to consider the impact of the biopharmaceutical industry on the economy.
|
September 2, 2011
By:Alan Sheppard
The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.
|
September 2, 2011
By:Fedra Pavlou
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
|
September 2, 2011
By:Angie Drakulich
Inside the National Institutes of Health
|
September 2, 2011
By:Raul Soikes
Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.
|
| 
